Arrowhead Pharmaceuticals, Inc. (ARWR)

NasdaqGS • Currently down 2.28 (-5.22%) in today's trading session

Track congressional stock trades in Arrowhead Pharmaceuticals, Inc. (ARWR). Analyse trading activity from Nancy Pelosi and other members of Congress using public financial disclosure data.

Arrowhead Pharmaceuticals, Inc. is currently trading at $41.37, positioned at 2% of its 52-week range ($40.43 – $95.49).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$41.37
24h Change
-2.28 (-5.22%)
52 Week Range
$40.43–$95.49
View on NASDAQ

Arrowhead Pharmaceuticals, Inc. Price History and Technical Analysis

Congressional Trading Activity for ARWR

Select to highlight on chart
0 transactions
Compliance: 100%
No data

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$5.85B

Volume

3.91M

Beta

1.37

P/E Ratio

-18.39

Fundamentals

EPS

$-2.25

Div. Yield

-

Open

$43.36

Day Range

$41.17 – $44.71

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
US
CEO
Christopher R. Anzalone
IPO Date
1993-12-16

Arrowhead Pharmaceuticals, Inc., founded in 1989 and based in Pasadena, California, is a biopharmaceutical company dedicated to discovering and advancing innovative treatments for complex and challenging-to-treat diseases within the United States. Th...

Earnings

Next Report

Q4 2026

4 Feb

EPS Est.

$-1.45

Rev. Est.

$48.7M

Days Until

74

Recent Quarters

Q3 202612 Nov
EPS$-3.04
Miss 100.0%
Q2 20264 Aug
EPS$-1.36
Miss 6.3%
Q1 20267 May
EPS$-0.93
Beat 14.7%
Q4 20255 Feb
EPS$0.22
Miss 63.3%
Q3 202525 Nov
EPS$-0.18
Miss 61.3%
Q2 20257 Aug
EPS$-1.26
Miss 34.0%
Q1 202512 May
EPS$2.75
Beat 4683.3%
Q4 202410 Feb
EPS$-1.39
Miss 230.9%
Q3 202426 Nov
EPS$-1.38
Miss 31.4%
Q2 20248 Aug
EPS$-1.38
Miss 137.9%
Q1 20249 May
EPS$-1.02
Miss 1600.0%
Q4 20236 Feb
EPS$-1.24
Miss 59.0%
Q3 202329 Nov
EPS$-1.03
Miss 47.1%
Q2 20237 Aug
EPS$-0.96
Miss 65.5%
Q1 20232 May
EPS$0.45
Beat 170.3%
Q4 20226 Feb
EPS$-0.39
Miss 134.2%
Q3 202228 Nov
EPS$-0.81
Miss 42.1%
Q2 20224 Aug
EPS$-0.68
Miss 51.1%
Q1 202210 May
EPS$0.41
Beat 612.5%
Q4 20212 Feb
EPS$-0.60
Miss 172.7%
Q3 202122 Nov
EPS$-0.61
Miss 478.5%
Q2 20215 Aug
EPS$-0.29
Miss 262.5%
Q1 20214 May
EPS$-0.26
Miss 188.9%
Q4 20204 Feb
EPS$-0.20
Miss 120.0%
Q3 202023 Nov
EPS$-0.48
Miss 241.2%
Q2 20205 Aug
EPS$-0.13
Miss 85.7%
Q1 20207 May
EPS$-0.20
Miss 81.8%
Q4 20195 Feb
EPS$-0.03
Miss 320.2%
Q3 201925 Nov
EPS$0.11
Miss 31.3%
Q2 20195 Aug
EPS$0.21
Miss 27.6%
Q1 20198 May
EPS$0.24
Beat 26.3%
Q4 20187 Feb
EPS$0.13
Miss 75.9%
Q3 201811 Dec
EPS$-0.12
Beat 29.4%
Q2 20187 Aug
EPS$-0.18
Beat 5.3%
Q1 20188 May
EPS$-0.18
Beat 0.0%
Q4 20179 Feb
EPS$-0.18
Beat 0.0%
Q3 201712 Dec
EPS$-0.14
Miss 16.7%
Q2 20173 Aug
EPS$-0.07
Beat 46.1%
Q1 20173 May
EPS$-0.08
Beat 33.3%
Q4 20166 Feb
EPS$-0.17
Beat 5.6%
Q3 201614 Dec
EPS$-0.31
Beat 6.1%
Q2 20169 Aug
EPS$-0.32
Beat 13.5%
Q1 201610 May
EPS$-0.35
Beat 5.4%
Q4 20159 Feb
EPS$-0.32
Beat 15.8%
Q3 201514 Dec
EPS$-0.42
Miss 31.3%
Q2 20154 Aug
EPS$-0.27
Beat 30.8%
Q1 201511 May
EPS$-0.33
Beat 5.7%
Q4 20149 Feb
EPS$-0.41
Miss 28.1%
Q3 201425 Nov
EPS$-0.33
Miss 32.0%
Q2 201412 Aug
EPS$-0.22
Beat 0.0%
Q1 20146 May
EPS$-0.31
Miss 72.2%
Q4 20134 Feb
EPS$-0.28
Miss 55.6%
Q3 201318 Dec
EPS$-0.38
Miss 111.1%
Q2 20137 Aug
EPS$-0.23
Miss 4.5%
Q1 20139 May
EPS$-0.41
Q4 201213 Feb
EPS$-0.33
Q3 201228 Dec
EPS$-0.38
Q3 201220 Dec
EPS$-0.43
Q1 20128 May
EPS$-0.50
Q4 20119 Feb
EPS$-0.25
Q3 201120 Dec
EPS$-0.27
Q2 20118 Aug
EPS$-0.25
Q1 201112 May
EPS$0.37
Q4 201010 Feb
EPS$-0.20
Q3 201022 Dec
EPS$-0.28
Q2 201012 Aug
EPS$-0.10
Beat 77.8%
Q1 201013 May
EPS$-0.30
Beat 26.8%
Q4 200911 Feb
EPS$-0.30
Beat 45.5%
Q2 200910 Aug
EPS$-0.58
Q1 200915 May
EPS$-1.23
Q4 20089 Feb
EPS$-1.87
Q3 200815 Dec
EPS$-2.02
Q2 200811 Aug
EPS$-1.93
Q1 200812 May
EPS$-1.47
Q4 200711 Feb
EPS$-1.35
Q3 200714 Dec
EPS$-1.96
Q2 20079 Aug
EPS$-3.43
Q1 200710 May
EPS$-1.80
Q4 20069 Feb
EPS$-1.08
Q3 200614 Dec
EPS$-2.57
Q2 20069 Aug
EPS$-1.18
Q1 200610 May
EPS$-0.97
Q4 20059 Feb
EPS$-1.12
Q3 200522 Dec
EPS$-0.96
Q2 200512 Aug
EPS$-1.62
Q1 200514 May
EPS$0.27
Q4 200411 Feb
EPS$-1.12
Q3 200416 Dec
EPS$-1.07
Q2 200416 Aug
EPS$-0.47
Q1 200414 May
EPS$0.04
Q4 200313 Feb
EPS$-0.36
Q4 200313 Jan
EPS$13.64
Q2 200313 Aug
EPS$-6.49
Q1 200315 May
EPS$-12.99
Q4 200218 Feb
EPS$-6.49
Q4 200210 Jan
EPS$-12.20
Q2 200219 Aug
EPS$-12.99
Q1 200217 May
EPS$-1.04
Q4 200113 Feb
EPS$-6.49
Q3 200124 Dec
EPS$-6.26
Q2 200113 Aug
EPS$-4.02
Q1 200115 May
EPS$-6.49
Q4 200020 Feb
EPS$-6.49
Q3 200022 Dec
EPS$5.53
Q2 200010 Aug
EPS$-6.49
Q1 200015 May
EPS$-6.49
Q4 199910 Feb
EPS$-6.49
Q4 199910 Jan
EPS$-5.00
Q2 199919 Aug
EPS$68.00
Q4 199831 Mar
EPS$-2.00
Q3 199831 Dec
EPS$-2.00
Q3 199823 Nov
EPS$-2.00
Q1 199813 May
EPS$-1.00

No dividend data available for this stock.

Stock Splits

Split History

17 Nov 2011Reverse Split
Ratio1:10
15 Jan 2004Reverse Split
Ratio1:65

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.